ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent...
Κύριοι συγγραφείς: | Schlatzer, C, Bratton, D, Craig, S, Kohler, M, Stradling, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
BMJ Publishing Group
2016
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
ανά: Craig, SE, κ.ά.
Έκδοση: (2012) -
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
ανά: Craig, SE, κ.ά.
Έκδοση: (2012) -
Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
ανά: Schulz, U, κ.ά.
Έκδοση: (2013) -
Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
ανά: Bratton, D, κ.ά.
Έκδοση: (2014) -
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
ανά: Ayers, L, κ.ά.
Έκδοση: (2009)